The primary objective of this study aims to investigate short-term add-on efficacy and mechanism of Panax notoginseng (Sanqi) for aspirin resistance in secondary stroke prevention via TLR4/MyD88/NF-κB signaling pathway with a more strictly randomized controlled trial (RCT). This evidence concerns the gene TLR4 and stroke disorder.